Matt Tierney, MS, NP, FAAN

Title(s)Professor, Community Health Systems
SchoolSchool of Nursing
Address2 Koret Way, #511E
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSF School of Nursing, San Francisco, CAMS2000ANP, PMHNP
    Collapse Awards and Honors
    UCSF Health2023UCSF PRIDE Experience Award, Team Category: Care at Home Team
    UCSF Academy of Medical Educators2021Excellence in Interprofessional Teaching Award
    American Psychiatric Nurses Association2020  - 2021President
    American Psychiatric Nurses Association2019APNA Award for Excellence in Leadership - APRN
    American Academy of Nursing2018Fellow
    San Francisco VA Health Care System20161st Place Improvement Fair for the Prescription Opioid Safety Team (POST)
    American Psychiatric Nurses Association, California Chapter2013Ann M. Wilkinson Nurse Psychotherapist Award

    Collapse Overview 
    Collapse Overview
    Matt Tierney is a Clinical Professor at the UCSF School of Nursing and Affiliated Faculty with the UCSF Philip R. Lee Institute for Health Policy Studies. His roles include Medical Director of Inpatient Substance Use Management at UCSF Health, and Clinical Director of Substance Use Treatment and Education for UCSF's Office of Population Health. The focus of his work is improving essential addiction treatment delivery locally, regionally and nationally. Matt has extensive clinical experience treating opioid use disorders in under-served populations, and has created and directed numerous novel clinical programs designed to increase access to substance use treatment. With national advanced-practice certifications in Addictions Nursing, Adult Primary Care, and Psychiatric-Mental Health, he has expertise in addressing both individual and systemic factors that are associated with substance use and addiction. He teaches treatment approaches for substance use disorders extensively throughout the UCSF Schools, and he is recognized regionally and nationally as a nurse educator in the treatment of opioid use and other substance use disorders.

    Collapse Research 
    Collapse Research Activities and Funding
    Closing the Opioid Treatment Gap Through Advance Practice Nursing Activation
    SAMHSA/CSAT H79TI0083993-01Sep 30, 2021 - Sep 29, 2024
    Role: Project Director
    Description: This grant supports the development and implementation of a nursing education curriculum to teach future Advance Practice Registered Nurses (APRNs) to prescribe medications for opioid use disorder (MOUD), with the aim of increasing the number of APRNs providing MOUD within their practice. The targeted population of learners includes future APRNs studying at the UCSF School of Nursing, plus nursing faculty supervisors and preceptors.

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain. J Subst Use Addict Treat. 2024 Feb; 157:209215. Chapman SA, Fraimow-Wong L, Phoenix BJ, Tierney M, Spetz J. PMID: 37979946.
      View in: PubMed   Mentions: Translation:Humans
    2. A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs. Subst Abus. 2023 10; 44(4):337-347. Bosley HG, Peña JM, Penn AD, Sorensen JL, Tierney M, Flentje A. PMID: 37902034.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    3. Closing the Opioid Treatment Gap Through Advance Practice Nursing Activation: Curricular Design and Initial Outcomes. J Addict Nurs. 2023 Oct-Dec 01; 34(4):240-250. Tierney M, Castillo E, Leonard A, Huang E. PMID: 38015575.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Enhancing engagement between legislators and nursing to increase buprenorphine access. Nurs Outlook. 2023 Jul-Aug; 71(4):102004. Finnell DS, Schimmels J, Tierney M. PMID: 37429154.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Reducing Drug Overdose Deaths: Significant Changes Needed in U.S. Drug Treatment Policy. J Psychosoc Nurs Ment Health Serv. 2023 Jun; 61(6):7-10. Tierney M, Flentje A. PMID: 37261971.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. A Focused Screening and Clinical Intervention with Streamlined Outpatient Linkage for Hospitalized Patients with Opioid Use Disorder Experiencing Homelessness. Subst Abuse. 2023; 17:11782218231166382. Oreper S, Bond A, Bazinski M, Tierney M, Fang M, Sankaran S, Rambachan A. PMID: 37051016; PMCID: PMC10084569.
      View in: PubMed   Mentions:
    7. Influences on advance practice nursing education to prescribe medications for opioid use disorder. Nurs Outlook. 2023 May-Jun; 71(3):101963. Phoenix BJ, Tierney M, Chapman SA, Spetz J. PMID: 37003088.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach. J Nurs Scholarsh. 2023 05; 55(3):655-664. Jones KF, O'Reilly Jacob M, Spetz J, Hailer L, Tierney M. PMID: 36624606; PMCID: PMC10159879.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Buprenorphine Treatment: Advanced Practice Nurses Add Capacity. Health Affairs. 2022; 9(41):1231-1237. Spetz, J., Hailer, L., Gay, C., Tierney, M., Schmidt, L. A., Phoenix, B., & Chapman, S. A. View Publication.
    10. Emergency Removal of Supervision Requirements for Psychiatric Mental Health Nurse Practitioners: A Mixed-Methods Survey. Psychiatr Serv. 2023 02 01; 74(2):127-133. O'Reilly-Jacob M, Tierney M, Freeman P, Perloff J. PMID: 36004434.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    11. Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements. JAMA Netw Open. 2022 05 02; 5(5):e225996. Spetz J, Hailer L, Gay C, Tierney M, Schmidt L, Phoenix B, Chapman S. PMID: 35552728; PMCID: PMC9099425.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    12. Eliminating the buprenorphine DEA X waiver is critical to promote health equity. Nursing Outlook. 2022; 1(70):5-7. Jones, K. F., O'Reilly-Jacob, M., & Tierney, M. (2022). View Publication.
    13. Improving Behavioral Health Services in the Time of COVID-19 and Racial Inequities. NAM Perspectives. Discussion Paper, National Academy of Medicine, Washington, DC. 2021. Shim, R. S., Tierney, M., Rosenzweig, M.H., and Goldman, H.H. View Publication.
    14. Don’t “Waive” Goodbye to Education for Opioid Use Disorder. NAM Perspectives. 2021. Bottner, R., J. Bratberg, M. Martin, M. Weimer, A. Jordan, and M. Tierney. . View Publication.
    15. Stewarding Access to Care: Where We've Been and Where We're Going. J Am Psychiatr Nurses Assoc. 2021 Sep-Oct; 27(5):415-417. Tierney M. PMID: 34651519.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Barriers and Facilitators of Advanced Practice Registered Nurse Participation in Medication Treatment for Opioid Use Disorder: A Mixed Methods Study. Journal of Nursing Regulation. 2021; 2(12):5-22. Spetz, J., Chapman, S., Tierney, M., Phoenix, B., & Hailer, L.
    17. Secure Your Mask First: The Importance of Self-Care. J Am Psychiatr Nurses Assoc. 2021 Jul-Aug; 27(4):334-336. Tierney M. PMID: 34116613.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. The Move Toward Person-Centered Systems of Care. J Am Psychiatr Nurses Assoc. 2021 May-Jun; 27(3):259-262. Tierney M. PMID: 33998327.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Person-Centered Mental Health Care Access, Equity, and Justice. J Am Psychiatr Nurses Assoc. 2021 Mar-Apr; 27(2):174-176. Tierney M. PMID: 33749387.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Transforming Mental Health And Addiction Services. Health Aff (Millwood). 2021 02; 40(2):226-234. Alegría M, Frank RG, Hansen HB, Sharfstein JM, Shim RS, Tierney M. PMID: 33476189.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    21. Improving Access to Care in the Context of Opportunity. J Am Psychiatr Nurses Assoc. 2021 Jan-Feb; 27(1):88-90. Tierney M. PMID: 33375890.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Psychiatric-Mental Health Nurses: Revolutionizing Access to Person-Centered Care. J Am Psychiatr Nurses Assoc. 2020 Nov/Dec; 26(6):595-597. Tierney M. PMID: 33047632.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. J Addict Nurs. 2020 Oct/Dec; 31(4):261-268. Jones J, Tierney M, Jacobs G, Chien SY, Mallisham S. PMID: 33264198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. "The Future of Nursing: Accelerating gains made to address the continuum of substance use". Arch Psychiatr Nurs. 2020 10; 34(5):297-303. Tierney M, Finnell DS, Naegle M, Mitchell AM, Pace EM. PMID: 33032749.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Letter to the Editor. J Addict Nurs. 2020 Jul/Sep; 31(3):144. Tierney M. PMID: 32868605.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Screening gender minority people for harmful alcohol use. PLoS One. 2020; 15(4):e0231022. Flentje A, Barger BT, Capriotti MR, Lubensky ME, Tierney M, Obedin-Maliver J, Lunn MR. PMID: 32255781; PMCID: PMC7138294.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    27. Nursing: Addressing substance use in the 21st century. Subst Abus. 2019; 40(4):412-420. Finnell DS, Tierney M, Mitchell AM. PMID: 31638876.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions. JAMA. 2019 04 09; 321(14):1407-1408. Spetz J, Toretsky C, Chapman S, Phoenix B, Tierney M. PMID: 30964519; PMCID: PMC6459110.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    29. Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder. J Am Psychiatr Nurses Assoc. 2019 Jul/Aug; 25(4):272-279. Zavod A, Akerman SC, Snow MM, Tierney M, Sullivan MA. PMID: 30569814.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder. J Am Psychiatr Nurses Assoc. 2019 Jul/Aug; 25(4):305-313. Tierney M, Melino K, Adeniji A, Shumway M, Allen IE, Waters CM. PMID: 30295107.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. "Improving nurses' attitudes toward patients with substance use disorders.". American Nurse Today. 2016; 11(11):6-9. Tierney, Matthew.
    32. A Skills-Based Curriculum for Teaching Motivational Interviewing-Enhanced Screening, Brief Intervention, and Referral to Treatment (SBIRT) to Medical Residents. MedEdPORTAL Publications. 2015. Azari S, Ratanawongsa N, Hettema J, Cangelosi C, Tierney M, Coffa D, Shapiro B, Jain S, Hersh D, Manuel J, Ciccarone D, Lum P. View Publication.
    33. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers. Subst Abus. 2015; 36(4):389-92. Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. PMID: 26587696.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Buprenorphine diversion and misuse in outpatient practice. J Addict Med. 2014 Sep-Oct; 8(5):327-32. Lofwall MR, Martin J, Tierney M, Fatséas M, Auriacombe M, Lintzeris N. PMID: 25221985.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. A nursing diagnostic perspective on proposed criteria for substance use disorders: what the DSM-5 is leaving out. Issues Ment Health Nurs. 2012 Sep; 33(9):613-7. Phoenix BJ, Tierney MJ. PMID: 22957955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Matt's Networks
    Concepts (79)
    Derived automatically from this person's publications.
    Co-Authors (16)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department